Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Optima HealthSTU:J3N 24 EBITDA Margin % is 12.71% as of Sep. 2025, which is 36% above its 10-year median of 9.33. GuruFocus rates STU:J3N with a GF Score™ of 24/100. The stock has 2 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Optima Health ranks better than 60.24% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Optima Health's EBITDA for the
six
months ended in Sep. 2025 was €8.7 Mil. Optima Health's Revenue for the
six
months ended in Sep. 2025 was €68.5 Mil. Therefore, Optima Health's EBITDA margin for the quarter that ended in Sep. 2025 was 12.71%.
Optima Health (STU:J3N) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Optima Health EBITDA Margin % Related Terms
Optima Health EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Optima Health's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:J3N vs VEEV, BTSG, TEM: EBITDA Margin % Comparison
For the Health Information Services subindustry, Optima Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Optima Health EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Optima Health's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Optima Health's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Optima Health (STU:J3N) has a EBITDA Margin % of 12.71% as of Sep. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Optima Health and its competitors. This is 36% above median its historical median of 9.33. Over the past decade, Optima Health's EBITDA Margin % has ranged from 7.78 to 14.43. According to the industry distribution chart, Optima Health ranks #264 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 39.8%.
Is Optima Health's EBITDA Margin % too high?
Optima Health's current EBITDA Margin % of 12.71% is 36% above median its 10-year median of 9.33. Over the past 10 years, this metric has ranged from a low of 7.78 to a high of 14.43. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Optima Health's value of 12.71% is 24.2% above this industry median. Based on the distribution chart, Optima Health ranks #264 out of 664 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Optima Health has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Optima Health's EBITDA Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Optima Health ranks #264 out of 664 companies for EBITDA Margin %. This puts Optima Health in the upper half of its industry. The industry median EBITDA Margin % is 10.24. Optima Health's value of 12.71% is 24.2% above this benchmark. Historically, Optima Health's own EBITDA Margin % has ranged from 7.78 to 14.43 over the past decade. While the company's 10-year median is 9.33 vs. the industry median of 10.24, Optima Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Optima Health's current EBITDA Margin % of 12.71% is 24.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Optima Health and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Optima Health's current EBITDA Margin % is 12.71%, which is 36% above median its own 10-year median of 9.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optima Health stock overvalued right now?
Optima Health (STU:J3N) has a current EBITDA Margin % of 12.71%. The current EBITDA Margin % is 12.71%, which is 36% above median its 10-year median of 9.33 and 24.2% above the Healthcare Providers & Services industry median of 10.24. Optima Health's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Optima Health (STU:J3N), the current EBITDA Margin % is 12.71% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Optima Health PLC is a provider of technology-enabled corporate health and wellbeing solutions in the occupational health sector. The group offers a comprehensive range of flexible and progressive services, from statutory-driven workplace health surveillance medicals to proactive and preventive interventions, as well as workplace health advice and attendance management assessments. These services are ultimately rehabilitation programs and pathways designed to help people return to work.
24GF Score
Get the complete analysis for STU:J3N
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:J3N has been successfully added to your 
